HomeCTXR • NASDAQ
add
Citius Pharmaceuticals Inc
Previous close
$0.68
Day range
$0.65 - $0.70
Year range
$0.60 - $1.40
Market cap
119.24M USD
Avg Volume
2.09M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 10.97M | 2.67% |
Net income | -8.54M | 18.83% |
Net profit margin | — | — |
Earnings per share | -0.05 | 28.57% |
EBITDA | -10.97M | -2.67% |
Effective tax rate | -1.71% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 12.56M | -56.79% |
Total assets | 90.71M | -12.98% |
Total liabilities | 10.74M | -13.59% |
Total equity | 79.97M | — |
Shares outstanding | 180.67M | — |
Price to book | 1.37 | — |
Return on assets | -29.16% | — |
Return on capital | -33.02% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -8.54M | 18.83% |
Cash from operations | -7.79M | 0.85% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -7.79M | 0.46% |
Free cash flow | -6.19M | -47.25% |
About
Founded
2007
Headquarters
Website
Employees
22